Artificial Intelligence Platform Demonstrates High Adherence in Patients Receiving Fixed-Dose Ledipasvir and Sofosbuvir: A Pilot Study.

Alain H Litwin,Laura Shafner,Brianna Norton,Matthew J Akiyama,Linda Agyemang, Mercedes Guzman,Tatiana Vera,Moonseong Heo

OPEN FORUM INFECTIOUS DISEASES（2020）

引用 6|浏览9

暂无评分

摘要

This study evaluated health outcomes among people who inject drugs who are infected with hepatitis C virus using an artificial intelligence platform. Mean (SD) cumulative adherence (visual confirmation of administration) was 91.3% (10.5%). Most subjects (88.2%) achieved >= 80% adherence to treatment, and 88.2% (15 of 17) achieved a sustained virologic response.

查看译文

关键词

adherence,HCV,PWID

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要